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Introduction
Microtubules (MTs) are filamentous structures required for var-
ious cellular processes, such as intracellular transport, cell divi-
sion, and locomotion. The remodeling of MT networks depends 
on MT dynamic instability—spontaneous switching between 
episodes of growth and shortening (Desai and Mitchison, 1997). 
Numerous cellular factors control MT polymerization, depoly-
merization, and pausing or transitions between different states 
(catastrophes and rescues; Desai and Mitchison, 1997; van der 
Vaart et al., 2009).
MTs are intrinsically asymmetric, and in cells, only one of 
the two MT ends, the plus end, can grow. Not surprisingly, it is an 
important site for the regulation of MT dynamics (Howard and 
Hyman, 2003). Among MT regulators, MT plus end–tracking 
proteins (+TIPs) are distinguished by their ability to form comet-
like accumulations at the ends of growing MTs (Schuyler and 
Pellman, 2001). +TIPs can influence MT dynamics in various 
ways: cytoplasmic linker proteins (CLIPs) and CLIP-associated 
proteins (CLASPs) stimulate rescues (Komarova et al., 2002; 
Mimori-Kiyosue et al., 2005), end-binding proteins (EBs) pro-
mote MT dynamicity and growth and suppress catastrophes 
(Tirnauer and Bierer, 2000; Komarova et al., 2009), and the MT 
depolymerase mitotic centromere-associated kinesin (MCAK) 
induces catastrophes (Howard and Hyman, 2007).
Although  many  +TIPs  can  interact  with  MTs  directly, 
most of them target growing MT ends by binding to the members 
of the EB family, which can autonomously localize to growing MT 
tips (Akhmanova and Steinmetz, 2008). The N-terminal part of 
the EBs consists of a calponin homology domain, which is the pri-
mary determinant of MT tip recognition (Komarova et al., 2009). 
T
he ends of growing microtubules (MTs) accumulate 
a set of diverse factors known as MT plus end–
tracking proteins (+TIPs), which control microtubule 
dynamics  and  organization.  In  this  paper,  we  identify 
SLAIN2 as a key component of +TIP interaction networks. 
We showed that the C-terminal part of SLAIN2 bound to 
end-binding  proteins  (EBs),  cytoplasmic  linker  proteins 
(CLIPs), and CLIP-associated proteins and characterized 
in detail the interaction of SLAIN2 with EB1 and CLIP-170. 
Furthermore, we found that the N-terminal part of SLAIN2 
interacted with ch-TOG, the mammalian homologue of the 
MT polymerase XMAP215. Through its multiple inter-
actions,  SLAIN2  enhanced  ch-TOG  accumulation  at   
MT plus ends and, as a consequence, strongly stimulated 
processive MT polymerization in interphase cells. Deple-
tion or disruption of the SLAIN2–ch-TOG complex led 
to disorganization of the radial MT array. During mito-
sis, SLAIN2 became highly phosphorylated, and its inter-
action with EBs and ch-TOG was inhibited. Our study 
provides new insights into the molecular mechanisms 
underlying cell cycle–specific regulation of MT polymer-
ization and the organization of the MT network.
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Figure 1.  SLAIN1 and SLAIN2 are EB-dependent +TIPs. (A and C) GST pull-down assays were performed with the indicated GST fusions and lysates of cells 
expressing different GFP-SLAIN1/2 fusions. Coomassie-stained gels are shown for GST fusions, and Western blots with anti-GFP antibodies are shown for 
GFP fusions. (B) Mapping of the minimal MT plus end–binding domain of SLAIN2 based on GST-EB1 binding and MT plus end tracking in live cells. CC, 1085 SLAIN2 promotes microtubule plus end growth • van der Vaart et al.
SLAIN2–ch-TOG complex has a profound effect on MT growth 
and organization in interphase, it does not affect mitotic pro-
gression. Our study provides new insights into the control of 
MT plus end dynamics during the cell cycle.
Results
Identification of SLAIN1 and SLAIN2 as 
EB-dependent +TIPs
To identify new EB-interacting partners, we performed GST 
pull-down assays combined with mass spectrometry using GST-
EB1 and different cell extracts (Fig. S1, A and B). Among the 
new potential EB partners was SLAIN2, which was initially de-
scribed as a homologue of SLAIN1, a protein named after an 
amino acid stretch in the C terminus that reads “SLAIN” (Hirst 
et al., 2006). SLAINs are present in all vertebrates, and two 
SLAIN homologues exist in mammalian genomes (Hirst et al., 
2006). Sequence analysis of SLAIN1 and SLAIN2 predicts a 
short coiled-coil domain at their N termini (Fig. S1 C). Analysis 
of a purified SLAIN2 N-terminal fragment (residues 1–43) by 
circular dichroism spectroscopy, thermal unfolding, and multi-
angle light scattering showed that it indeed folds into a two-
stranded -helical coiled-coil structure (Fig. S1, D–F). The 
remaining SLAIN1/2 sequence is rich in serines, prolines, and 
basic residues, encompasses no conserved sequence regions, 
and is predicted to be largely unstructured.
Mass  spectrometry  results  were  validated  by  GST-EB 
pull-down assays with the extracts of cells overexpressing GFP-
tagged SLAIN1/2 (Fig. 1 A). Next, we performed GST-EB pull-
down assays with different deletion mutants of SLAIN2 (Fig. 1, 
B and C). The C-terminal part of SLAIN2 contains four SxIP-like 
sequence motifs as well as a more distantly related motif, RSLP, 
which are potential EB1 binding sites and MT plus end local-
ization signals (Fig. S1 C; Honnappa et al., 2009). Indeed, two 
short nonoverlapping C-terminal fragments of SLAIN2 could 
interact  with  EB1  in  GST  pull-down  assays,  indicating  that 
SLAIN2 has several tandemly arranged EB1 binding sites (Fig. 1, 
B and C). Both GFP-SLAIN1 and 2 as well as short EB1-binding 
fragments of SLAIN2 colocalized with EB-positive MT ends 
(Fig. 1, B and D; Video 1; and not depicted).
To investigate whether the SxIP-like sites in SLAIN2 are 
required for MT tip tracking, the IP/LP dipeptides within the iden-
tified sites were mutated to asparagines (Fig. 1 B and Fig. S1 C). 
Mutation of the first four sites considerably diminished, but did 
not abolish, plus end tracking of the C-terminal SLAIN frag-
ment (Video 2). Next, we introduced additional mutations in the 
fifth, more divergent site, RSLP, as well as two other even more 
deviant potential EB1 binding sites containing a hydrophobic 
residue followed by a proline (Fig. S1 C and not depicted). 
The C-terminal part of the EBs includes an EB homology (EBH) 
domain that encompasses a coiled-coil and a four-helix bundle 
and an acidic tail with a conserved terminal tyrosine residue 
reminiscent of the ones of -tubulin and CLIP-170 (Akhmanova 
and Steinmetz, 2008). To date, two types of interactions be-
tween the EBs and their partners have been characterized in 
detail.  Proteins  containing  cytoskeleton-associated  protein 
(CAP)–Gly domains, such as CLIPs, interact with the EEY/F 
motifs of the EB tails whereby the C-terminal tyrosine is re-
quired for efficient binding (Honnappa et al., 2006; Weisbrich 
et al., 2007). A large number of other EB partners, including 
CLASPs and MCAK, associate with a hydrophobic cavity of 
the EBH domain through basic and serine-rich regions contain-
ing the short linear motif SxIP (Honnappa et al., 2009). +TIP 
interactions with the EBs are transient and competitive, as EB 
dimers can associate with only two CAP-Gly domains or SxIP 
motifs at the same time. Additional enrichment of +TIPs at the 
MT ends can be achieved by binding to other +TIPs (Akhmanova 
and Steinmetz, 2008). For example, CLASPs associate with 
the coiled-coil part of CLIPs independently of EB binding 
(Akhmanova et al., 2001). +TIPs thus form an intricate and dy-
namic protein network at growing MT plus ends (Akhmanova 
and Steinmetz, 2008).
A highly conserved and essential +TIP family is repre-
sented by XMAP215 in Xenopus laevis and Dis1 in the fission 
yeast (Slep, 2009). XMAP215 was shown to track MT ends pro-
cessively and autonomously and to act as an MT polymerase 
(Brouhard et al., 2008). Experiments in Xenopus egg extracts in-
dicated that XMAP215 is a major MT-stabilizing factor in both 
mitosis and interphase (Tournebize et al., 2000). In addition to 
promoting MT polymerization, XMAP215 can also counteract 
the MT-destabilizing activity of the MT depolymerase XKCM1 
(Tournebize et al., 2000; Kinoshita et al., 2001). The mammalian 
homologue of XMAP215, ch-TOG, also promotes MT assembly 
in vitro (Charrasse et al., 1998; Bonfils et al., 2007). The cellular 
function of ch-TOG has been predominantly studied in mitosis, 
in which it is essential for proper spindle assembly and organiza-
tion (Gergely et al., 2003; Cassimeris and Morabito, 2004; 
Holmfeldt et al., 2004; Barr and Gergely, 2008; Cassimeris et al., 
2009). However, the role of ch-TOG in interphase cells has not 
been addressed in detail, and it is unknown whether this protein 
behaves as an authentic +TIP.
In this study, we identify SLAIN as a new +TIP that asso-
ciates with EBs, CLASPs, CLIPs, and ch-TOG. We provide evi-
dence that the SLAIN2–ch-TOG complex enriched at MT ends 
through association with EBs and possibly other +TIPs strongly 
promotes processive MT growth. During cell division, SLAIN2 
is phosphorylated, and thereby, its interaction with the EBs and 
ch-TOG is inhibited. Therefore, although the disruption of the 
coiled coil; B/S, basic and serine rich; Y, C-terminal tyrosine. Asterisks indicate SxIP-like motifs. Mutations in the SxIP-like sites are indicated by red asterisks 
(see Fig. S1 C for the sequence of SLAIN2). (D) Live-cell imaging of HeLa cells transiently transfected with EB3–monomeric RFP and GFP-SLAIN1/2. Red and 
green images were collected simultaneously with a beam splitter and a 0.5-s interval; five consecutive frames were averaged. (E) IPs from HeLa cell extracts 
with rat monoclonal antibodies against HA tag (control) or EB1 and EB3 were analyzed by Western blotting with the indicated antibodies. White lines 
indicate that intervening lanes have been spliced out. (F and H) 3T3 cells were transfected with the indicated siRNAs, fixed, and stained with the indicated 
antibodies. The insets show enlargements of the boxed areas. In the overlay, EB1 is shown in green, and SLAIN2 is shown in red. (G) Extracts of 3T3 cells 
transfected with the indicated siRNAs analyzed by Western blotting with the indicated antibodies. Endog., endogenous; SL2, SLAIN2; WB, Western blot.
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Figure 2.  SLAIN2 interacts with CLIPs and CLASPs. (A) HeLa cells were transiently transfected with GFP-SLAIN2, fixed, and labeled with the indicated 
antibodies. Insets show enlargements of the boxed areas. (B and C) GST pull-down assays were performed with the indicated GST fusions and lysates of 
untransfected HeLa cells or cells expressing the indicated GFP fusions (SLAIN2 is abbreviated as SL2). Western blots were performed using the antibodies 1087 SLAIN2 promotes microtubule plus end growth • van der Vaart et al.
significant interaction with full-length CLIP-170 (Fig. 2 B). We 
hypothesized that this was caused by the formation of an auto-
inhibitory loop within CLIP-170 blocking the binding of CAP-
Gly domains with their partners (Lansbergen et al., 2004). To 
test this idea, we performed GST pull-down assays with GFP–
CLIP-170 N terminus (GFP–CLIP-170-N) or full-length GFP–
CLIP-115, two proteins that contain CAP-Gly domains but lack 
the inhibitory C terminus of CLIP-170 (Lansbergen et al., 2004). 
We  found  that  both  of  them  associated  with  the  SLAIN2   
C terminus (Fig. 2 B). Purified biotinylated and GFP-tagged 
SLAIN2 (BioGFP-SLAIN2) bound to purified GST–CLIP-170-N 
as well as GST-EB3 (Fig. 2 C), confirming that the interactions 
of SLAIN2 with CLIP-170 and EBs are direct and do not de-
pend on the presence of each other or additional +TIPs.
A conspicuous feature of SLAIN sequences is the pres-
ence of a highly conserved tyrosine at the outmost C terminus, 
which is similar to that of -tubulin, EBs, and CLIP-170 (Fig. 2 D). 
In the latter proteins, the C-terminal aromatic residue of the EEY/F 
motif is essential for binding to CAP-Gly domains (Komarova   
et al., 2005; Honnappa et al., 2006; Mishima et al., 2007; Weisbrich 
et al., 2007). To determine whether this is also true for the SLAIN2–
CLIP-170 interaction, we generated GFP-SLAIN2 deletion mu-
tants lacking the last 20 amino acids (GFP–SLAIN2-C) or only 
the C-terminal tyrosine (GFP–SLAIN2-Y). Both mutants co-
localized with endogenous EB1 at MT plus ends and interacted 
with GST-EB3 in pull-down experiments but displayed no bind-
ing to GST–CLIP-170-N (Fig. S2 C and Fig. 2 C). Moreover, 
MT bundles induced by these SLAIN2 mutants failed to recruit 
CLIP-170, indicating that the C-terminal tyrosine in SLAIN2 is 
important for the interaction with CLIP-170 in cells (Fig. S2 C 
and not depicted).
Biophysical and structural analysis of the 
SLAIN2–CLIP-170 interaction reveals a 
new CAP-Gly domain-binding mode
To investigate the SLAIN2–CLIP-170 interaction in more detail, 
we performed isothermal titration calorimetry (ITC) experiments 
with a 13–amino acid peptide of SLAIN2 C terminus (SLAIN2c) 
and with the CAP-Gly domains of CLIP-170 (CLIPCG1 and 
CLIPCG2). Analysis of the data yielded equilibrium dissociation 
constants (Kd’s) in the micromolar range (Fig. 2 E and Fig. S2 D). 
A comparable Kd was obtained for the double CAP-Gly con-
struct CLIPCG12, which bound two SLAIN2c peptides (Fig. 2 E 
and Fig. S2 D). In contrast, only very weak binding was observed 
These mutations further reduced plus end tracking (with the 
RSLP site at position 560 having the strongest contribution to 
plus end tracking; Fig. S1 C and Video 2), but we still observed 
a very weak association of the resulting mutants with the grow-
ing MT ends as well as binding to EB1 (Video 2 and not de-
picted). We conclude that SxIP-like sites in SLAIN2 strongly 
contribute to its plus end–tracking behavior but that additional 
weak EB1 and MT tip binding sites that do not match the SxIP 
consensus are present within the SLAIN2 C terminus.
To study endogenous SLAINs, we raised an antibody that 
recognized both GFP-SLAIN1 and GFP-SLAIN2 (Fig. S1 G). 
On Western blots of different cell lines, this antibody recognizes 
protein bands of 75–85 kD (Fig. S1 H), which is in agreement 
with the predicted molecular mass of SLAIN1/2. The presence 
of multiple bands is likely explained by the existence of alterna-
tively spliced isoforms, phosphorylation, and/or degradation. 
Endogenous SLAIN1/2 coprecipitates with EB1 (Fig. 1 E) and 
colocalizes with it at MT plus ends (Fig. 1 F). The accumulation 
of SLAINs at MT tips depends on EBs, as it is strongly reduced 
after siRNA-mediated knockdown of EB1 and EB3 (Fig. 1, 
G and H). Based on these findings, we conclude that SLAIN1/2 
accumulate at MT plus ends in an EB-dependent manner.
SLAINs associate with CLIPs
Although at low expression levels, exogenous SLAINs deco-
rated  only  MT  plus  ends,  at  high  expression  levels,  GFP-
SLAIN2 bound along MTs and formed bundles of acetylated 
MTs (Fig. S2 A). The formation of these bundles was dependent 
on  the  presence  of  EB  proteins  because,  in  EB1/3-depleted 
cells, SLAIN2 did not associate with MTs but formed aggre-
gates (Fig. S2 B). In line with these data, we could detect no direct 
interaction between SLAIN2 and MTs in MT-pelleting assays 
(unpublished data), indicating that SLAIN2 has no high intrin-
sic affinity for MTs.
Interestingly, CLASPs and CLIP-170 were also recruited 
to MT bundles induced by SLAIN overexpression (Fig. 2 A and 
Fig. S2 A). Previous studies have shown that +TIPs compete for 
EB binding and that their simultaneous recruitment to MT bun-
dles is observed only when they can interact with each other 
in an EB-independent manner (Mimori-Kiyosue et al., 2005; 
Weisbrich et al., 2007). This suggests a direct interaction be-
tween SLAIN2 and CLIP-170 and/or CLASPs.
To test this possibility, we performed pull-down assays 
using GST fusions of SLAIN2 N and C termini but found no 
against GFP or CLASP1. The top lane of C shows a GST pull-down assay with BioGFP-SLAIN2 purified from HEK293 cells. White lines indicate that inter-
vening lanes have been spliced out. (D) Alignment of the C-terminal tails of human EB1, EB2, EB3, -tubulin (-tub.), CLIP-170, and SLAIN1 and SLAIN2 
from different species. Hs, Homo sapiens; Gg, Gallus gallus; Xt, Xenopus tropicalis; Dr, Danio rerio; Ci, Ciona intestinalis. The conserved C-terminal aro-
matic and the tryptophan residues are highlighted. (E) Equilibrium dissociation constants obtained by ITC for the complexes of the human SLAIN2 peptide 
(SLAIN2c) with either the first (CLIPCG1), second (CLIPCG2), or both (CLIPCG12) CAP-Gly domains of CLIP-170. (F) Overall view of the heterodimeric 
complex formed between CLIPCG1 (surface representation) and SLAIN2c (sticks representation). Contact modes A and B are shown in red and blue, re-
spectively. (G and H) Close up views of the interaction network seen in the complex formed between SLAIN2c (yellow carbon atoms) and CLIPCG1 (gray 
carbon atoms) in the cartoon (main chain) and sticks (contacting residues) representation. Panels G and H depict contact modes A and B, respectively.   
(I and J) Overall view of the heterodimeric complex formed between CLIPCG1 (ribbon representation) and SLAIN2c (sticks representation; I) and super-
position of complexes formed between CAP-Gly domains and C-terminal tyrosine or phenylalanine-containing sequence regions (J). For simplicity, only the 
last three C-terminal residues of the respective CAP-Gly ligands are shown in sticks representation. (K) IP with anti-GFP antibodies from extracts of HeLa 
cells expressing GFP or GFP-SLAIN2 fusions were analyzed by Western blotting with the indicated antibodies. (L) Mapping of the SLAIN2 interaction site 
with CLIP-170, EB3, CLASP1, and MT plus ends. (M) Schematic overview of the SLAIN2–CLIP-170 interaction. CC, coiled-coil; B/S, basic and serine rich;   
Y, C-terminal tyrosine; Zn, zinc knuckles; F, C-terminal phenylalanine; Endog., endogenous; PDB, Protein Data Bank.
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GST–SLAIN2-C1 (Fig. 2 B). The CLASP–SLAIN2 interaction 
was also independent of CLIP-170, as immunoprecipitation (IP) 
experiments showed that both GFP-SLAIN2 C-terminal mutants 
that do not bind CLIP-170 could still coprecipitate CLASP1 
(Fig. 2 K). Collectively, our results show that the SLAIN2-C1 
binds to EBs, CLIPs, and CLASPs (Fig. 2, L and M). Targeting of 
SLAIN2 to the MT plus ends depends on EBs (Fig. 1, F and H), 
whereas GFP-SLAIN2 still localizes to MT tips in cells de-
pleted of CLIP-170 and CLASPs (Fig. S2 G). The interactions 
with CLIPs and CLASPs are likely needed to avoid competition 
between these proteins at MT tips.
To  identify  additional  SLAIN  partners,  we  performed 
streptavidin-based pull-down assays of BioGFP-SLAIN1/2 from 
HeLa cells (Fig. 3 A) and analyzed the resulting proteins by 
mass spectrometry. The experimental set up was validated by 
the identification of CLASP1 among the proteins associated 
with BioGFP-SLAIN2 (Fig. S3 A). Furthermore, on a Coomassie-
stained gel, a prominent band of 220 kD was visible in both 
SLAIN1 and SLAIN2 lanes (Fig. 3 A). This protein was identi-
fied as ch-TOG (Fig. S3 A).
Although it is generally accepted that XMAP215 and its 
homologues act at MT tips (Brouhard et al., 2008), the vertebrate 
members of the XMAP215/Dis1 family have not been shown to 
form comet-like accumulations at MT ends in cells. Using live-
cell imaging, we could detect GFP-tagged ch-TOG at the growing 
MT ends, where it colocalized with SLAIN1/2 and EBs (Fig. 3 B, 
Video 3, and not depicted). Endogenous SLAIN and ch-TOG 
were coprecipitated with endogenous EB1 and with each other 
(Fig. 1 E and Fig. 3 C). Endogenous ch-TOG was also coprecipi-
tated with full-length GFP-SLAIN2 and with its mutants deficient 
in CLIP-170 binding, demonstrating that the SLAIN2–ch-TOG 
interaction does not require CLIP-170 (Fig. 2 K).
EBs and SLAIN2 promote ch-TOG 
accumulation at MT tips
In agreement with previous studies, we found that endogenous 
ch-TOG localized to centrosomes in interphase and to spindle 
poles and MTs in mitosis (unpublished data; Tournebize et al., 
2000; Gergely et al., 2003). In addition, ch-TOG colocalized 
with endogenous EBs at the MT plus ends of interphase cells 
(Fig. 3 D). By performing a double knockdown of EB1 and 
EB3, we found that ch-TOG requires EBs for efficient comet-
like accumulation at the MT plus ends but not at the centrosome 
(Fig. 3 E and not depicted).
Next,  we  investigated  the  hierarchy  of  SLAIN  and   
ch-TOG interactions with MT plus ends. In HeLa cells, all 
SLAIN-specific bands could be depleted by different siRNAs 
against SLAIN2, whereas SLAIN1-specific siRNAs had no ef-
fect. This result suggests that HeLa cells do not express SLAIN1, 
a conclusion supported by RT-PCR analysis (Fig. S3, B and C). 
Using  the  SLAIN2  siRNA#2,  we  could  efficiently  deplete 
SLAIN2 also from mouse 3T3 cells (Fig. S3 D and Fig. 3 F). 
Interestingly, in cells depleted of SLAIN2, EB1/3 comets dis-
played little ch-TOG labeling (Fig. 3 G), indicating that SLAIN2 
participates in ch-TOG recruitment to MT ends. In contrast, 
both CLASPs and CLIPs could still be detected at the plus ends 
of SLAIN2-depleted cells (Fig. S3, E and F).
between SLAIN2c and the CAP-Gly domain of the dynactin 
large subunit p150
Glued (p150CG; Fig. S2 D), indicating that the 
C-terminal regions of SLAINs specifically target the CAP-Gly 
domains of the CLIPs.
Next, we solved the structure of the SLAIN2c–CLIPCG1 
complex by x-ray crystallography (Table S1). As illustrated in 
Fig. 2 (F–J), the overall structure reveals a heterodimeric com-
plex formed between one CLIPCG1 and one SLAIN2c molecule. 
The CLIPCG1 subunit displays all features of the CAP-Gly fold 
(Steinmetz and Akhmanova, 2008). The six C-terminal SLAIN2c 
residues are tightly packed against the CLIPCG1 fold and as-
sume a looplike conformation (Fig. 2, F–J; and Fig. S2 E).
Analysis of the SLAIN2c–CLIPCG1 binding interface re-
veals two contact sites, referred to as A and B. Contact A 
(Fig. 2 G) involves residues from a distinct groove shaped by 
hydrophobic and polar side chains of CLIPCG1 and the last two 
C-terminal residues, Cys580 and Tyr581, of SLAIN2c. The side 
chain of Tyr581, including its -carboxylate group, is inserted 
at one end of the CLIPCG1 groove and is specifically recog-
nized by a set of amino acid residues that are highly conserved 
across CAP-Gly domain homologues (Steinmetz and Akhmanova, 
2008). The binding mode of contact A is nearly identical to 
the ones seen between the CAP-Gly domain of p150
Glued and 
the C-terminal domains of EB1 (Honnappa et al., 2006) and 
CLIP-170 (Weisbrich et al., 2007) and between the second CAP-
Gly domain of CLIP-170 and a peptide derived from the C ter-
minus of -tubulin (Fig. 2 J; Mishima et al., 2007). The importance 
of the tyrosine residue for the interaction of the C-terminal 
SLAIN2 peptide with the two CAP-Gly domains of CLIP-170 
was confirmed by ITC (Fig. S2 D).
Contact B (Fig. 2 H) involves residues from a second, dis-
tinct groove shaped by hydrophobic and polar side chains of 
CLIPCG1 and Trp576 and Lys577 of SLAIN2c (Fig. S2 E). The 
side chain of Trp576, which is highly conserved among SLAIN 
orthologues (Fig. 2 D), is inserted into this groove and is fur-
ther buried by the hydrophobic moiety of Lys577. Substitution 
of Trp576 for alanine abrogates binding of the mutant SLAIN2c 
peptide  (SLAIN2c-W576A)  to  CLIPCG1  and  CLIPCG2 
(Fig. S2 D), demonstrating the importance of this conserved 
residue for binding to the CAP-Gly domains of CLIP-170. In-
terestingly, the CLIPCG1 residues that contact Trp576 as well as 
the 1-2 loop, which establishes one wall of the groove, are 
only partially conserved in p150CG (Fig. S2 F) and other CAP-
Gly domain homologues (Steinmetz and Akhmanova, 2008). 
Because p150CG binds SLAIN2c more weakly than the two 
CAP-Gly domains of CLIP-170 (Fig. S2 D), we propose that 
these residues play an important role in determining the speci-
ficity of CAP-Gly domains for tryptophan side chains that 
precede C-terminal aromatic residues.
SLAINs associate with CLASPs and ch-TOG
Next, we investigated the association of SLAIN2 with CLASPs. 
Endogenous CLASPs were pulled down by GST–SLAIN2-C1 
(Fig. 2 B and not depicted). Although this interaction might 
be indirect, it was not mediated by EB1, as CLASP2-M, a 
CLASP2 deletion mutant lacking the EB1 binding site (Komarova 
et al., 2002; Mimori-Kiyosue et al., 2005), could still bind to 1089 SLAIN2 promotes microtubule plus end growth • van der Vaart et al.
Figure 3.  SLAIN2 interacts with ch-TOG and promotes its MT plus end accumulation. (A) Streptavidin pull-down assay from HeLa cells expressing BioGFP 
or BioGFP-SLAIN1 (SL1) or -SLAIN2 (SL2) together with BirA. Proteins were analyzed by Coomassie staining. The arrow indicates ch-TOG, and the arrow-
head indicates BioGFP-SLAIN1/2. (B) Live imaging of HeLa cells transiently expressing GFP–ch-TOG alone (top) or in combination with mCherry-SLAIN2 
(bottom) collected as described for Fig. 1 D. The top right image shows maximum intensity projection of two consecutive averaged frames displayed in 
green and red. Insets show enlarged views of individual MT plus ends. (C) IPs from HeLa cell extracts with either the IgG control or SLAIN1/2 antibody 
were analyzed by Western blotting with the indicated antibodies. (D–I) 3T3 cells were transiently transfected with different siRNAs, fixed, and stained with 
the indicated antibodies. The insets show enlargements of the boxed areas. Arrowheads in I indicate MT plus ends. In the overlay in D, G, and I, EB1/3 
is in red, and ch-TOG or SLAIN1/2 is in green. (J) Quantification of the number of EB1/3-positive comets per 100-µm
2 surface area in control 3T3 cells 
or cells depleted of SLAIN2 or ch-TOG (11–14 cells were analyzed for each condition). Error bars show SD. Values significantly different from control are 
indicated with asterisks; ***, P < 0.001. Endog., endogenous.JCB • VOLUME 193 • NUMBER 6 • 2011   1090
Collectively, these results indicate that SLAIN2 can pro-
mote the binding between ch-TOG and EB1 and potentially 
other +TIPs (Fig. 4 I) and help to recruit ch-TOG to MT plus 
ends and to maintain the normal number of growing MTs.
SLAIN2–ch-TOG complex is required for 
persistent MT growth and  
radial MT organization
To analyze the effect of the loss or disruption of the SLAIN2–
ch-TOG complex on MT growth, we used HeLa cells stably ex-
pressing fluorescently tagged tubulin. We followed the dynamics 
of freshly polymerized MTs in the internal cytoplasm after photo-
bleaching of the preexisting MTs (Fig. 5 A). We found that the 
length of MT stretches polymerized after FRAP was dramati-
cally reduced in cells that were depleted of SLAIN2 and ch-TOG 
or that were expressing the dominant-negative SLAIN1/2-N1 
mutants (Fig. 5, A and B). The mean MT elongation rate, deter-
mined using fluorescently tagged tubulin or EB3-GFP without 
taking into account short pauses or depolymerization events, 
was reduced approximately twofold (Fig. 5, C and D; and not 
depicted). This change in rate was primarily caused by a two- to 
threefold increase in the catastrophe frequency (Fig. S5 A and 
Table S2). Although in control cells, MT growth episodes were 
relatively “smooth,” in SLAIN2- and ch-TOG–depleted cells, 
they were continuously interrupted by short depolymerization 
events or pauses, an effect that was particularly obvious in ky-
mograph analysis (Fig. 5 E, Table S2, and Fig. S5 A). Interest-
ingly, although the instantaneous rate of MT growth bursts was 
not significantly changed (Fig. S5 B), EB3-GFP comets became 
shorter (Fig. 5, F and G; and Video 4), suggesting an altered state 
of the MT plus end. The MT depolymerization rate was not sig-
nificantly affected, and the rescue frequency remained high (it 
was even elevated in SLAIN2-depleted, but not in ch-TOG– 
depleted, cells (Fig. S5 A and Table S2). The frequent switching 
between short episodes of growth and depolymerization led to a 
strong overall decrease in MT elongation (Fig. 5, C–E).
An increased catastrophe frequency was also observed 
after depletion of SLAIN2 and ch-TOG in 3T3 and CHO cells 
(Fig. S5 A and Table S2). We have shown previously that in the 
latter cell type, most of the growing MTs emerging from the 
centrosome extend persistently to the cell periphery and that 
80% of the MT growth tracks visualized by EB3-GFP are lon-
ger than half of the mean cell radius (7.5 µm; Komarova et al., 
2009). Depletion of SLAIN2 and ch-TOG reduced this value to 
<10% (Fig. 5, F and H), which is consistent with a strong in-
crease in catastrophe frequency.
The depletion of ch-TOG and SLAIN2 might also cause a 
reduction in the number of growing MT ends by affecting MT 
nucleation, as XMAP215/Dis1 proteins play an important role 
at the centrosome (see Cassimeris et al., 2009 and references 
therein).  Indeed,  MT  nucleation  frequency  determined  with 
EB3-GFP was significantly reduced after SLAIN2 and ch-TOG 
knockdown  (Fig.  5  I).  The  involvement  of  the  SLAIN2– 
ch-TOG complex in MT nucleation was further supported by 
the fact that its disruption by overexpressing SLAIN1/2 N ter-
mini strongly delayed MT recovery after nocodazole treatment: 
10 min after the drug washout, the MT network was almost 
Next, we used siRNAs to deplete endogenous ch-TOG. 
Because of the strong mitotic arrest caused by ch-TOG knock-
down (Gergely et al., 2003; Cassimeris and Morabito, 2004), 
we enriched interphase cells by applying a thymidine block for 
2 d. Knockdown of ch-TOG in HeLa and 3T3 cells could be 
confirmed both by Western blotting (Fig. S3, D and G) and by 
immunostaining  (Fig.  3  H).  Although  SLAIN2  levels  were 
somewhat reduced in ch-TOG–depleted cells, it could still be 
detected at the EB1/3-positive MT tips (Fig. S3, D and G; and 
Fig. 3 I), indicating that SLAIN2 acts upstream of ch-TOG with 
respect to MT tip localization.
Both SLAIN2 and ch-TOG depletion strongly reduced the 
number and length of EB1/3-positive comets (Fig. 3 J and not 
depicted), suggesting a defect in MT growth. An overall disor-
ganization of the MT network was also observed: instead of the 
radial array typical for 3T3 fibroblasts, MTs often appeared to 
be circularly arranged and entangled (Fig. S3 H).
SLAIN2 promotes the interaction between 
EB1 and ch-TOG
To characterize the SLAIN2–ch-TOG interaction in more detail, 
we performed pull-down experiments with deletion mutants of 
the two proteins. We found that the whole N-terminal half of 
SLAIN2 (SLAIN2-N1), but not its shorter fragments, bound to 
ch-TOG; this interaction depended on the C-terminal domain of 
ch-TOG (Fig. 4, A–D). Using GST pull-down assays, we found 
that, as expected, GFP-SLAIN2, but not GFP–SLAIN2-N1, was 
pulled down by GST-EB1 (Fig. 4 E). Endogenous ch-TOG also 
interacted with GST-EB1, in line with our mass spectrometry 
data (Fig. 4 E and Fig. S1 B). This interaction was increased 
when GFP-SLAIN2 was overexpressed (Fig. 4 E and Fig. S4 A), 
suggesting that full-length SLAIN2 can stabilize the binding be-
tween ch-TOG and EB1. In agreement with this idea, we found 
that GFP–ch-TOG-C1, which localized at centrosomes and in 
the cytosol of control cells (Fig. S4 B) was recruited to MT plus 
ends when SLAIN2 levels were elevated by expressing mCherry-
SLAIN2 (Fig. S4 C). On the other hand, when GFP–SLAIN2-N1 
was overexpressed, endogenous ch-TOG could no longer be de-
tected at the MT plus ends, and its interaction with GST-EB1 
was strongly reduced (Fig. 4, E and F; and Fig. S4 A), indicating 
that the SLAIN2 N terminus uncouples ch-TOG from EB1.
Next, we examined the functional consequences of the 
disruption of the ch-TOG–EB1 interaction caused by over-
expression of GFP–SLAIN2-N1 and found that it induced a strong 
reduction in the number of EB1-positive MT tips, whereas MT 
density remained unchanged (Fig. 4, G and H; and Fig. S4 D). 
Overexpression of the SLAIN1 N terminus caused an identical 
phenotype (Fig. 4 H and Fig. S4 D), suggesting that the func-
tions of SLAIN1 and SLAIN2 are similar. Reduction in the 
number of EB1 comets was also observed in cells overexpress-
ing the ch-TOG C terminus, which is also expected to uncouple 
endogenous ch-TOG from SLAIN and EB1 (Fig. S4, B and E) 
as well as after SLAIN2 and ch-TOG depletion (Fig. 3 J, Fig. 4 H, 
and Fig. S4 D). Importantly, the number of growing MT ends 
was fully rescued by stable expression of low levels of GFP-
SLAIN2 in SLAIN2-depleted cells (Fig. 4 H), confirming the 
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Figure 4.  SLAIN2 links ch-TOG to EB1. (A) Mapping of the ch-TOG–binding domain of SLAIN1 and 2 (SL1 and SL2). CC, coiled coil; B/S, basic and 
serine rich; Y, C-terminal tyrosine. The ability to exert a dominant-negative (DN) effect on the number of EB1-positive MT tips is indicated. (B) Streptavidin 
pull-down assays were performed with extracts of HEK293 cells coexpressing BioGFP-SLAIN2 mutants and BirA and analyzed by Western blotting with 
the indicated antibodies. (C) Mapping of the SLAIN2-binding domain of ch-TOG. (D and E) GST pull-down assays were performed with the indicated GST 
fusions and lysates of HEK293 cells expressing GFP fusions of ch-TOG or SLAIN2. Coomassie-stained SDS-PAGE is shown for GST fusions. Western blots 
with anti-GFP antibodies are shown for GFP fusions and with ch-TOG antibodies for endogenous (Endog.) ch-TOG. White lines indicate that intervening 
lanes have been spliced out. (F and G) 3T3 (F) or HeLa cells (G) were transfected with GFP–SLAIN2-N1, fixed, and labeled with the indicated antibodies. 
In F, the insets show enlargements of the boxed areas where 1 is an untransfected control cell and 2 is a GFP–SLAIN2-N1–transfected cell. (H) Quantifica-
tion of the number of EB1-positive comets per 100-µm
2 surface area in control or GFP–SLAIN1/2-N1–expressing HeLa cells. Approximately 10–50 cells 
were analyzed in each experiment. Error bars show SD. Statistically significant differences are indicated (**, P < 0.01; ***, P < 0.001). (I) A scheme of 
the identified interactions between SLAIN2, ch-TOG, EB1, CLASPs, and CLIP-170.JCB • VOLUME 193 • NUMBER 6 • 2011   1092
Figure 5.  SLAIN2 and ch-TOG promote MT growth. (A) HeLa cells stably expressing GFP– or mCherry–-tubulin were transfected with the indicated 
siRNAs. FRAP assay was performed 72 h later in an internal part of the lamella indicated by a stippled line. Video frames at 33 s after FRAP are shown. 
Newly polymerized MTs are indicated by arrows. (B) Share of freshly polymerized MT segments longer than 2 µm 30 s after FRAP. Approximately 230–300 1093 SLAIN2 promotes microtubule plus end growth • van der Vaart et al.
domain) and C termini (the EB1-, CLIP-, and CLASP-binding 
domains) showed strongly reduced electrophoretic mobility in 
mitotically blocked cells (Fig. 6 F). These results indicate that 
mitotic hyperphosphorylation inhibits the interaction of SLAIN2 
with EB1 and ch-TOG.
To investigate which kinase is responsible for SLAIN2 
phosphorylation, HeLa cells stably expressing GFP-SLAIN2 
were blocked in mitosis and subsequently released for 1 h in the 
presence of different kinase inhibitors. Inhibition of Cdk1 using 
RO-3306  or  flavopiridol  caused  a  strong  downward  shift  of 
GFP-SLAIN2 protein bands on Western blots (Fig. 6, G and H). 
This increase in GFP-SLAIN2 electrophoretic mobility was not 
caused by proteasome activity, as it was also observed in the 
presence of the proteasome inhibitor MG132 (Fig. 6, G and H). 
Inhibitors of other kinases, such as Plk1 or GSK3-, had no ef-
fect (Fig. 6 G). Sequence analysis of SLAIN2 predicts multiple 
major (S/TPxPK/R) and minor (S/TP) Cdk1 consensus sites, 
and several of them are indeed phosphorylated based on mass 
spectrometry  analysis  (Fig.  S1  C),  suggesting  that  SLAIN2 
might be a direct target of Cdk1. Collectively, these data 
show that in mitosis, the interaction of SLAIN2 with EB1 
and ch-TOG is inhibited by phosphorylation and that SLAIN2-
dependent recruitment of ch-TOG to MT tips is, thus, confined 
to interphase cells.
Discussion
In this study, we identified SLAINs as +TIPs and showed that 
SLAIN2 plays an important role in regulating MT growth and 
organization by interacting with multiple +TIPs and targeting 
ch-TOG to growing MT plus ends. Similar to many +TIPs 
(Akhmanova and Steinmetz, 2008), SLAINs bind to EBs and 
depend on them for MT tip accumulation. In addition, the   
C-terminal part of SLAIN2 interacts with the CLASPs and the 
CLIPs. The SLAIN2–CLIP interaction involves the C-terminal 
tail of SLAINs and the CAP-Gly domains of CLIPs. Notably, 
the conserved terminal tyrosine residue of SLAIN2 is recog-
nized by the CAP-Gly fold in exactly the same way as the ones 
of the EEY/F motifs of EBs, -tubulin, and CLIP-170. How-
ever, although in EBs, -tubulin, and CLIP-170, the acidic resi-
dues of EEY/F contribute to the stability of the complexes through 
electrostatic interactions (Mishima et al., 2007), a conserved 
completely restored in control cells but was virtually absent in 
cells expressing SLAIN1/2 N termini (Fig. 5, J and K).
We  further  found  that  in  all  situations  in  which  the 
SLAIN2–ch-TOG complex was depleted or disrupted, MTs 
were severely disorganized: instead of running from the cell 
center to the cell periphery, MTs were arranged at random   
angles and strongly entangled (Fig. 5, L and M; Fig. S3 H; and 
Fig. S5 C). Collectively, these data show that SLAIN2 and 
ch-TOG act as major MT growth-promoting factors by stimu-
lating MT nucleation and growth and suppressing catastrophes. 
They further indicate that SLAIN2- and ch-TOG–dependent 
processive MT polymerization is an important factor for main-
taining normal interphase MT array.
Mitotic phosphorylation of SLAIN2 
disrupts the EB1–SLAIN2–ch-TOG complex
Depletion of ch-TOG causes severe mitotic defects (Gergely   
et al., 2003; Cassimeris and Morabito, 2004; Holmfeldt et al., 
2004). Indeed, ch-TOG knockdown induced a strong increase 
in the mitotic index of HeLa cells (Fig. 6 A). In contrast, two of 
the three SLAIN2 siRNAs that efficiently deplete SLAIN2 
(Fig. S3 B) caused no increase in the proportion of mitotic cells 
(Fig. 6 A) and no apparent abnormalities of the mitotic appara-
tus (not depicted). Localization experiments using a HeLa cell 
line stably expressing GFP-SLAIN2 showed that it dissociated 
from MT plus ends and the centrosome early in prophase and 
remained cytosolic until late telophase (Fig. 6 B, Video 5, 
Video 6, and Video 7).
Western blot analysis of extracts of cells blocked in mito-
sis showed that endogenous SLAIN2 and GFP-SLAIN2 protein 
bands are very strongly up-shifted (Fig. 6, C and D). Incubation 
of immunoprecipitated SLAIN2 with  phosphatase completely 
reversed this shift, indicating that it is caused by phosphoryla-
tion (Fig. 6, C and D). The presence of multiple phosphorylated 
sites in SLAIN2 isolated from mitotic cells was confirmed by 
mass spectrometry (Fig. S1 C).
In agreement with the absence of GFP-SLAIN2 at the MT 
plus ends in mitosis, hyperphosphorylated GFP-SLAIN2 did 
not associate with GST-EB1 in a GST pull-down assay (Fig. 6 E). 
Furthermore, mitotic phosphorylation also inhibited coprecipi-
tation of SLAIN2 and ch-TOG (Fig. 6, C and D). In line with 
these observations, both SLAIN2 N (the ch-TOG–binding   
growth episodes were analyzed in 15–20 cells for each condition. (C and D) Mean MT elongation rate was measured in internal cytoplasm over periods 
of 10–50 s from the moment of appearance of the growing MT end until the end of the video or until a catastrophe leading to a processive MT-shortening 
episode with the length of >1 µm. Analysis was performed in HeLa cells stably expressing EB3-GFP that were transfected with the indicated siRNAs (C) or 
in HeLa cells stably expressing mCherry–-tubulin transfected with GFP or GFP–SLAIN1/2-N1 (D). Approximately 70–100 growth episodes in 10–20 cells 
were analyzed for each condition. (E) Kymographs illustrating MT growth using mCherry–-tubulin or EB3-GFP after different siRNA treatments or in cells 
expressing GFP alone (control) or GFP–SLAIN1/2-N1. (F) CHO cells were transiently transfected with EB3-GFP and the indicated shRNAs. Live images 
were collected with a 0.5-s time interval. Single frames (top) and maximum intensity projections of 100 frames (bottom) are shown. (G) Length of EB3-GFP 
comets in control, SLAIN2, or ch-TOG–depleted cells determined from live imaging experiments shown in F. Approximately 300 MT tips were analyzed in 
15 cells per condition. (H and I) Proportion of MT tracks originating from the centrosome with the length exceeding 7.5 µm (H) and MT nucleation frequency 
from the centrosome in CHO cells transiently transfected with EB3-GFP and the indicated shRNAs (I). In H, 100 MT growth episodes were analyzed in 
15 cells per condition. In I, 10 cells were analyzed per condition. (J and K) MT recovery after nocodazole washout. HeLa cells expressing GFP or 
GFP–SLAIN1/2-N1 for 1 d were treated with 10 µm nocodazole for 2 h. The drug was washed out with fresh medium, and cells were fixed and stained   
10 min later (J). The number of MTs per 100 µm
2 was counted in 20 cells for each condition (K). (L and M) MT organization in HeLa cells transiently express-
ing GFP or GFP–SLAIN1/2-N1 1 d after transfection. Cells were stained for -tubulin (L), and the angles of MT segments in relation to the long axis of the 
lamella were measured. Angle distributions measured in 10 cells and their Gaussian fits are shown for each condition (M). Transfected cells are indicated 
by asterisks in J and L. In C, D, G–I, and K, the values significantly different from controls are indicated with asterisks (**, P < 0.01; ***, P < 0.001).
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Figure 6.  Mitotic phosphorylation disrupts SLAIN2 interaction with MTs, EB1, and ch-TOG. (A) Proportion of mitotic HeLa cells identified by staining with 
antibodies against histone H3 phosphorylated at serine 10 after transfection with the indicated siRNAs. (B) HeLa cells stably expressing GFP-SLAIN2 (SL2) 
were fixed and stained with anti-EB1 antibodies. The prophase cell was distinguished by the strong increase in centrosomal MT nucleation. Insets show 
enlargements of the boxed areas. (C) IPs with anti-SLAIN1/2 antibodies from control HeLa cells or cells blocked in mitosis with 0.1 µM nocodazole. Where 
indicated, immunoprecipitated material was treated on beads with  phosphatase. Western blotting was performed with the indicated antibodies. (D) The 
same experiment as in C but using a GFP-SLAIN2 stable HeLa cell line and anti-GFP antibodies. (E) GST pull-down assays were performed with GST or 
GST-EB1, and cell extracts were prepared as in D. (F) The same experiment as in C but using HeLa cells transiently expressing N- and C-terminal fragments 
of SLAIN2. (G and H) HeLa cells stably expressing GFP-SLAIN2 were blocked in mitosis with 7.5 µM STLC (G) or 0.1 µM nocodazole (H) and released 
for 1 h into medium containing either the indicated inhibitors, 20 mM NaCl, or 20 mM LiCl. White lines indicate that intervening lanes have been spliced 
out. S, STLC; N, nocodazole; FP, flavopiridol; Endog., endogenous; Cont., control; Mit., mitotic; Extr., extract.1095 SLAIN2 promotes microtubule plus end growth • van der Vaart et al.
and other +TIPs is needed to gain access to growing MT tips 
that are strongly occluded by EBs and their numerous partners.
Although SLAINs are conserved in vertebrates and tuni-
cates, we could identify no apparent SLAIN counterparts in 
other taxa, possibly because of a low degree or absence of se-
quence conservation. Alternatively, lower organisms might not 
need  accessory  factors  for  XMAP215/Dis1  homologues  be-
cause they are expressed at higher levels or because their +TIP 
networks are less complex.
Because SLAINs localize to MT tips by interacting with 
EBs and EB partners (Fig. 7), one could expect that EB depletion 
should have an MT growth phenotype similar to that of ch-TOG 
or SLAIN2. Our previous study showed that the depletion of 
EBs indeed increased the catastrophe frequency (Komarova   
et al., 2009), but the effect was relatively mild. This difference 
could be caused by the difficulty to completely deplete all three 
mammalian EBs (Komarova et al., 2009). Alternatively, EBs can 
concentrate at MT tips not only in MT-stabilizing proteins, such 
as  CLASPs,  but  also  destabilizing  factors,  such  as  MCAK 
(Montenegro Gouveia et al., 2010). Therefore, when EBs are 
knocked down, the balance of regulatory activities at MT ends 
might not be significantly shifted. In contrast, SLAIN2 or ch-TOG 
depletion affects only growth-promoting, but not destabilizing, 
activities at MT tips, and MT polymerization is inhibited.
Overall, our functional data are consistent with the view 
that in interphase cells, SLAIN2 primarily acts as a ch-TOG co-
factor at growing MT ends. Remarkably, the SLAIN–ch-TOG 
as well as SLAIN–EB partnership is disrupted during cell division. 
tryptophan in SLAIN2 interacts with a distinct hydrophobic 
cavity present in the CAP-Gly domains of CLIP-170. Our struc-
tural data therefore extend the specificity portfolio of CAP-Gly 
domains and explain the functional role of the evolutionarily 
conserved SLAIN C terminus.
SLAINs combine different and multiple copies of major 
+TIP elements, such as SxIP-like and EEY/F-like motifs, in one 
molecule (Fig. 7). This unique property of SLAINs is expected 
to enable them to associate simultaneously with several differ-
ent +TIPs and, thus, promote formation of +TIP interaction net-
works with multiple and partly redundant binding nodes (Fig. 7). 
The functional significance of each particular interaction might 
be relatively small; however, their overall effect would be to en-
able SLAINs to act as adhesive +TIP factors, which have a con-
tinuous access to growing MT ends, enhance +TIP interactions, 
and promote their access to the MT ends.
Importantly, we found that SLAINs use their adhesive 
properties to robustly target ch-TOG to growing MT plus ends. 
ch-TOG binds to SLAINs through its C-terminal part, which is 
distinct from its tubulin-binding TOG domains, necessary for 
MT polymerase activity (Slep, 2009). SLAINs likely promote 
the activity of ch-TOG by positioning it close to growing MT 
ends. However, in vitro XMAP215 can autonomously track MT 
plus ends (Brouhard et al., 2008) and stimulate MT growth in 
the absence of other +TIPs (Kinoshita et al., 2001). So why 
would the members of the XMAP215/Dis1 family need an ac-
cessory factor in vivo? We propose that in cells, the ability of 
XMAP215/Dis1 family members to interact with EB proteins 
Figure 7.  A scheme of SLAIN2-linked +TIP network and its biological role. Different types of +TIP interactions are indicated by different colors. The po-
tential direct EB1–ch-TOG interaction based on the data from other species (Rehberg and Gräf, 2002; Wolyniak et al., 2006; Kronja et al., 2009) is not 
depicted. SLAIN2-dependent interactions enhance ch-TOG accumulation at the MT tip. ch-TOG, in turn, promotes processive MT growth that is required 
for proper MT organization.JCB • VOLUME 193 • NUMBER 6 • 2011   1096
2006);  EB3,  5-CUAUGAUGGAAAGGAUUAC-3  (Komarova  et  al., 
2005);  CLIP-170,  5-GGAGAAGCAGCAGCACAUU-3  (Lansbergen   
et al., 2004); CLASP1, 5-GCCAUUAUGCCAACUAUCU-3; and CLASP2, 
5-GUUCAGAAAGCCCUUGAUG-3  (Mimori-Kiyosue  et  al.,  2005). 
Synthetic oligos were transfected using a transfection reagent (HiPer-
Fect; QIAGEN) at a concentration of 5 nM. Cells were analyzed 72 h 
after transfection.
Drug treatments
In the case of siRNA-mediated ch-TOG and SLAIN2 knockdown, 3T3 and 
HeLa cells were blocked in interphase 1 d after transfection by adding 2 mM 
thymidine (Sigma-Aldrich) to culture medium for 2 d. HeLa cells were blocked 
in mitosis by a 16 h treatment with 0.1 µM nocodazole (Sigma-Aldrich) or 
with 7.5 µM S-trityl-l-cysteine (STLC; Eg5 inhibitor; Sigma-Aldrich). Cells 
were released from the mitotic block for 60 min in the presence of the fol-
lowing inhibitors: 10 µM RO-3306 (EMD), 100 nM BI-2536 (Selleck), 20 mM 
LiCl, 10 µM flavopiridol (Sigma-Aldrich), and 20 µM MG132 (Sigma- 
Aldrich).  Nocodazole  washout  experiments  were  performed  by  applying   
10 µM nocodazole for 2 h followed by washout of the drug for 5–20 min.
RT-PCR
Total RNA was isolated from HeLa cells using RNA-Bee (Tel-Test, Inc.) ac-
cording to the manufacturer’s protocol. cDNA was generated using a re-
verse transcription system (First-Strand cDNA synthesis SuperScript II RT; 
Invitrogen). Human brain cDNA was a gift from E. Mientjes (Erasmus MC, 
Rotterdam, Netherlands). Primers used for amplification of SLAIN2 were as 
follows: forward, 5-TAAGTGCTTCAGAATTAGAT-3; and reverse, 5-CATC-
ATGCAGTATACCCTG-3. SLAIN1 primers were previously described 
(Smith et al., 2010).
Protein purification, peptide preparation, pull-down assays,  
and protein analysis
GST fusions of the N-terminal and C-terminal fragments of SLAIN2 were 
generated in pGEX-4T-1. GST-EB1, -EB2, -EB3, –EB1-N (amino acids   
1–124), and –EB1-C (amino acids 125–268) were generated in pGEX-3X   
using full-length mouse EB1 and EB2 (long isoform) and human EB3 (long 
isoform) cDNAs (Komarova et al., 2005). GST–CLIP-170-N (amino acids 
1–310  of  rat  CLIP-170)  was  described  previously  (Lansbergen  et  al., 
2004). GST pull-downs, IPs, and Western blotting were performed accord-
ing to Komarova et al. (2005) and Lansbergen et al. (2004). Treatments 
with  phosphatase (New England Biolabs, Inc.) were performed on beads 
after GST pull-down assays or IP. All GST fusions were expressed in BL21 
E. coli and purified with glutathione–Sepharose 4B (GE Healthcare) ac-
cording to the manufacturer’s instructions. The His6-tagged SLAIN2 frag-
ment (amino acids 1–43) was inserted in the vector PSTCm1 (Olieric et al., 
2010). It was expressed in BL21 (DE3; Agilent Technologies) and purified 
by  immobilized  metal  affinity  chromatography  on  Ni
2+-Sepharose  (GE 
Healthcare) followed by size exclusion chromatography using a separa-
tion column (Superdex 200 10/300 GL; GE Healthcare). Identity of the 
protein  was  confirmed  by  liquid  chromatography/mass  spectrometry. 
BioGFP-SLAIN2 was purified from HEK293T cells. 70% confluent HEK293T 
cells were cotransfected with the constructs BioGFP-SLAIN2 and BirA using 
Lipofectamine 2000. 1 d after transfection, cells were lysed in a buffer 
containing 20 mM Tris-HCl, 100 mM KCl, 1% Triton X-100, and protease 
inhibitors (Complete; Roche) and purified with Mutein beads (Roche) ac-
cording to the manufacturer’s instructions.
Human CLIP-170 and p150
Glued fragments CLIPCG1 (residues 56–
128), CLIPCG2 (residues 210–282), CLIPCG12 (residues 48–300), and 
p150CG (residues 18–111) were cloned into pETG20A-MTA using the 
Gateway cloning system (Invitrogen) and purified as previously described 
in Weisbrich et al. (2007). In brief, transformed E. coli strains BL21 (DE3; 
Agilent Technologies; for CLIPCG1, CLIPCG2, and p150CG) and C41 
(DE3; Lucigen; for CLIPCG12) were grown at 37°C in Luria-Bertani media 
to an OD600 of 0.7. Expression was induced with 1mM IPTG and per-
formed overnight at 20°C. The His6-tagged fusion proteins were affinity 
purified by immobilized metal affinity chromatography on Ni
2+-Sepharose 
at 4°C. Proteolytic cleavage to remove the His6 tag was performed at 4°C 
using human thrombin (Sigma-Aldrich). Cleaved proteins were subjected to 
a second Ni
2+-Sepharose column and further purified by size exclusion 
chromatography on Superdex 75 (CLIPCG1, CLIPCG2, and p150CG) or 
Superdex 200 columns (CLIPCG12; GE Healthcare) equilibrated in PBS 
(137 mM NaCl, 2.7 mM KCl, 8.3 mM Na2HPO4, and 1.47 mM KH2PO4, 
pH 7.4). Throughout the CG12 purification, reducing conditions (1 mM 
-mercaptoethanol) were maintained. The homogeneity of the recombinant 
proteins was assessed by SDS-PAGE, and their identity was confirmed by 
mass spectral analysis.
As the cell proceeds from interphase into mitosis, MT dynam-
ics drastically changes, and MT turnover strongly increases 
(Wittmann et al., 2001). Our data suggest that phosphorylation 
of SLAIN2 at the onset of mitosis is part of this mitosis-specific 
regulatory switch in MT dynamics. It remains to be investigated 
whether, in mitosis, ch-TOG targets MT tips autonomously or 
uses some additional partners. In conclusion, our study identi-
fies SLAIN2 as an important component of a complex MT plus 
end–targeting mechanism and reveals the function of SLAIN2 
in the cell cycle–regulated control of MT dynamics.
Materials and methods
Constructs
GFP-SLAIN1 and -SLAIN2 expression constructs and their deletion mutants 
were  generated  using  the  mouse  cDNA  IMAGE  (integrated  molecular 
analysis of genomes and their expression) clone 6811096 and the human 
cDNA KIAA1458 (a gift from Kazusa DNA Research Institute) in pEGFP-C1 
by PCR-based strategies. In BioGFP fusions, a linker encoding the sequence 
MASGLNDIFEAQKIEWHEGGG,  which  is  the  substrate  of  biotin  ligase 
BirA is inserted into the NheI and AgeI sites in front of the GFP (pBioGFP-C1). 
The BirA ligase expression construct, which contains the Escherichia coli 
BirA open reading frame fused to the triple HA tag and cloned into the cyto-
megalovirus enhancer and promoter-containing vector pSCT (Driegen et al., 
2005) was a gift from D. Meijer (Erasmus MC, Rotterdam, Netherlands). 
mCherry-SLAIN1/2 were made by recloning SLAIN1/2 into MluI–EcoRI 
sites of a modified pEGFP vector in which the GFP open reading frame was 
substituted for that of mCherry (a gift from R. Tsien, University of California, 
San Diego, San Diego, CA; Shaner et al., 2004). GFP–ch-TOG, based 
on a human ch-TOG cDNA in pEGFP-C–based vector, was a gift from   
L. Wordeman (University of Washington, Seattle, WA); this construct was used 
for generating ch-TOG deletion fragments in pBioGFP-C1 by a PCR-based 
strategy. We also used the following previously described pEGFP-C1–
based expression constructs: GFP–-tubulin, encoding human -tubulin 
(Takara Bio Inc.), GFP–CLIP-115, which encodes full-length rat CLIP-115 
(De Zeeuw et al., 1997), GFP–CLIP-170, which encodes full-length rat CLIP-
170 (Hoogenraad et al., 2000), GFP–CLIP-170-N, which encodes amino 
acids  4–309  of  the  rat  CLIP-170  (Komarova  et  al.,  2002)  and  GFP–
CLASP2-M, which encodes amino acids 36–340 fused in frame to amino 
acids 581–1,294 of CLASP2- (Mimori-Kiyosue et al., 2005). mCherry–
-tubulin contained a human -tubulin coding sequence N-terminally fused 
to mCherry (Shaner et al., 2004). EB3-GFP, based on the human cDNA, 
was generated in pEGFP-N1 (Stepanova et al., 2003). Point mutations in 
the  GFP–SLAIN2-C3  fragment  were  introduced  by  overlapping  PCR. 
pSuper-based small hairpin RNA (shRNA) vectors (Brummelkamp et al., 
2002) were directed against the following target sequences: mouse/rat 
ch-TOG,  5-AGAGTCCAGAATGGTCCAA-3;  and  mouse/rat/human 
SLAIN2, 5-CTCTATAGATAGTGAGTTA-3.
Cell culture, stable cell lines, and transfection of DNA constructs
HeLa, Swiss 3T3, CHO, and HEK293 were cultured in medium which con-
sisted of 45% DME, 45% Ham’s F10, and 10% fetal calf serum supple-
mented with penicillin and streptomycin (Akhmanova et al., 2001). HeLa 
cell lines stably expressing GFP–-tubulin, EB3-GFP (Mimori-Kiyosue et al., 
2005), mCherry–-tubulin (Splinter et al., 2010), GFP-SLAIN2, and the 
GFP-SLAIN2 #3 rescue construct and the 3T3 cell line stably expressing 
EB3-GFP  were  selected  using  FACS  and  cultured  in  the  presence  of   
0.4 mg/ml G418 (Roche). PolyFect (QIAGEN), FuGENE 6 (Roche), or Lipo-
fectamine 2000 (Invitrogen) reagents were used for plasmid transfection.
siRNAs
siRNAs were synthesized by Invitrogen or Thermo Fisher Scientific. They 
were directed against the following target sequences: SLAIN1 #1, 5-GAC-
AUGUAGUGAACAAGAA-3; SLAIN1 #2, 5-GUAACAUGCCUUUAU-
CAAA-3; SLAIN1 #3, 5-GCAGCAACAGUAUUAUUC-3; SLAIN2 #1, 
5-GCGCAGUUCUGGUUCAUCU-3;  SLAIN2  #2,  5-CUCUAUAGAU-
AGUGAGUUA-3;  SLAIN2  #3,  5-GGAACUUGAUGCACAAAGU-3; 
control,  5-GCACUCAUUAUGACUCCAU-3  (Mimori-Kiyosue  et  al., 
2005); human ch-TOG, 5-GAGCCCAGAGUGGUCCAAA-3 (Cassimeris 
and  Morabito,  2004);  mouse  ch-TOG,  ON-TARGETplus  SMARTpool   
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positive protein hit was set to 60. Individual peptide tandem mass spec-
trometry spectra with Mascot scores <40 were checked manually and ei-
ther interpreted as valid identifications or discarded. Proteins present in the 
negative controls (pull-down assays with either GST or bioGFP alone) were 
omitted from the table.
Phosphorylated peptides were selectively enriched in an offline chro-
matographic manner using a TiO2 (Titansphere) packed fused silica capil-
lary that is used as a trap, which acts as an 1D separation step in a 2D 
chromatography system (Pinkse et al., 2004). Phosphorylated peptides were 
separated from nonphosphorylated peptides by trapping them under acidic 
conditions on the TiO2 column and ultimately desorbed under alkaline condi-
tions, dried, and dissolved in 0.1 M formic acid. Subsequently, nanoflow liq-
uid chromatography with tandem mass spectrometry was performed on an 
capillary liquid chromatography system (1100 series) coupled to a mass 
spectrometer (LTQ Orbitrap) operating in positive mode and equipped with 
a nanospray source as described in the previous paragraph. The Mascot 
search algorithm (version 2.2) was used for searching against the Interna-
tional Protein Index database (release number IPI_human_20100507).
Antibodies and immunofluorescent cell staining
Rabbit antibodies against SLAIN1/2 were raised against a bacterially 
purified GST-SLAIN2 N terminus. We used rabbit polyclonal antibodies 
against GFP (Abcam), CLASP1 (Mimori-Kiyosue et al., 2005), CLASP2, 
CLIP-170 (Akhmanova et al., 2001), EB3 (Stepanova et al., 2003), phos-
phorylated histone H3 (Ser 10; Millipore), cyclin B1 (GNS1; Santa Cruz 
Biotechnology, Inc.), and ch-TOG (a gift from L. Cassimeris, Lehigh Uni-
versity, Bethelehem, PA; Charrasse et al., 1998); mouse monoclonal anti-
bodies against GFP and HA tag (Roche), EB1 (BD), -tubulin, acetylated 
tubulin (Sigma-Aldrich), p150
Glued (BD), and actin (Millipore); and the rat 
monoclonal antibody against EB1/3 (clone 15H11; Absea) and HA tag 
(Roche). The following secondary antibodies were used: alkaline phos-
phatase–conjugated  anti–rabbit,  anti–mouse,  or  anti–rat  antibodies 
(Sigma-Aldrich); goat anti–rabbit, anti–mouse, and anti–rat IgG (IRDye 
800CW; LI-COR Biosciences); and Alexa Fluor 350–, Alexa Fluor 488–, 
and Alexa Fluor 598–conjugated goat antibodies against rabbit, rat, 
and mouse IgG (Invitrogen).
Cultured cells were fixed with 20°C methanol for 15 min in the 
case of EB1/3, ch-TOG, CLASP1/2, and p150
Glued labeling. In the case of 
EB1, SLAIN1/2, CLIP-170, acetylated tubulin, and -tubulin labeling, cells 
were fixed with 20°C methanol for 15 min and postfixed in 4% PFA in 
PBS for 15 min at RT. Cells were rinsed with 0.15% Triton X-100 in PBS; 
subsequent washing and labeling steps were performed in PBS supple-
mented with 1% bovine serum albumin and 0.15% Tween 20. At the end, 
slides were rinsed in 100% ethanol, air dried, and mounted in mounting 
medium (Vectashield; Vector Laboratories).
Image acquisition and processing
Images of fixed cells were collected with a microscope (DMRBE; Leica) 
equipped with PL Fluotar 100× 1.3 NA or 40× 1.00–0.50 NA oil objec-
tives with a FITC/EGFP filter 41012 (Chroma Technology Corp.) and Texas 
red filter 41004 (Chroma Technology Corp.) and a charge-coupled device 
(CCD) camera (ORCA-ER-1394; Hamamatsu Photonics).
Live-cell  imaging  was  performed  on  an  inverted  research  micro-
scope (Eclipse Ti-E; Nikon) with a Perfect Focus System (Nikon), equipped 
with CFI Apo total internal reflection fluorescence (TIRF) 100× 1.49 NA oil 
objective (Nikon) and an EMCCD camera (QuantEM 512SC; Roper Scien-
tific) and controlled with MetaMorph 7.5 software (Molecular Devices). 
The 16-bit images were projected onto the CCD chip with intermediate 
lens 2.5× at a magnification of 0.065 µm/pixel. To keep cells at 37°C, we 
used a stage-top incubator (model INUG2E-ZILCS; Tokai Hit); cells were 
imaged in the normal culture medium. The microscope was equipped with 
a TIRF-E motorized TIRF illuminator modified by Roper Scientific (PICT-IbiSA; 
Institut  Curie).  For  regular  imaging,  we  used  a  mercury  lamp  (HBO-
100W/2; Osram) for excitation or 491-nm 50-mW Calypso (Cobolt) and 
561-nm 50-mW Jive (Cobolt) lasers. We used an ET-GFP filter set (Chroma 
Technology Corp.) for imaging of proteins tagged with GFP and an   
ET-mCherry filter set (Chroma Technology Corp.) for imaging of proteins 
tagged with mCherry. For simultaneous imaging of green and red fluores-
cence, we used an ET-mCherry/GFP filter set together with an imaging sys-
tem (Dual View DV2; Roper Scientific) equipped with dichroic filter (565 
DCXR; Chroma Technology Corp.) and an emission filter (HQ530/30m; 
Chroma Technology Corp.).
The FRAP assay was performed using a FRAP scanning system   
(I-Las/I-Launch [Roper Scientific]; PICT-IBiSA [Institut Curie]) installed on the 
same microscope and with the lasers mentioned in the previous paragraph 
at 100% laser power.
The  SLAIN2c  (residues  569–581  of  human  SLAIN2),  SLAIN2c-
W576A, and SLAIN2c-Y581 peptides were purchased from United Pep-
tide. The purity of the peptides was verified by reversed-phase analytical 
HPLC, and their identities were assessed by mass spectral analysis.
Size exclusion chromatography coupled to multiangle light scattering 
was performed on a three-angle detector (DAWN EOS; Wyatt) followed by a 
refractometer (Optilab Rex; Wyatt). Protein solutions (100 µl of 1–15 mg/ml) 
were injected on a size exclusion chromatography column (Superdex 
200 10/300 GL) equilibrated with PBS. Molecular weights were calculated 
by using the ASTRA V version 5.3.4.19 software package (Wyatt).
Far-UV circular dichroism spectroscopy was performed on a spec-
trometer (Chirascan-plus; Applied Photophysics) equipped with a tempera-
ture-controlled quartz cell of 0.1-cm path length. A ramping rate of 1°C/min 
was used to record thermal unfolding profiles. Midpoints of the transitions 
(Tm’s) were taken as the maximum of the derivative (d): d[]222/dT, in which 
T is the temperature.
ITC
ITC experiments were performed in PBS at 25°C on a calorimeter (iTC200; 
MicroCal) machine. The sample cell was filled with 160–240 µM CAP-Gly 
solutions. The syringe was filled with 2.2–2.6 mM SLAIN2c peptide solu-
tions. In the experiment with CLIPCG12, the buffer was supplemented with 
1 mM -mercaptoethanol. 2.6-µl SLAIN2c aliquots from the stirred syringe 
were injected 14–28 times into the sample cell. To determine the binding 
stoichiometry and the equilibrium dissociation constant (Kd) of the binding, 
isotherms were fitted using a nonlinear least squares minimization method 
provided with the ITC calorimeter. Exact concentrations of protein solutions 
were determined by absorbance at 280 nm in 6 M GuHCl for the CAP-Gly 
domains or by quantitative amino acid analysis for the SLAIN2c peptide.
Crystal structure determination
For crystallization, CLIPCG1 and SLAIN2c in PBS were mixed in a 1:1.2 
ratio to reach a final complex concentration of 24 mg/ml. Crystals were 
obtained at 20°C by the hanging-drop vapor diffusion method from a 1:1 
mixture of the complex solution and a reservoir composed of 36% PEG 
6000 and 100 mM citric acid, pH 4.5.
X-ray diffraction data were collected at 100 K at beamline X06DA 
of the Swiss Light Source (Villigen PSI). The structure was solved by molecu-
lar replacement using the CLIP-170 CAP-Gly structure as a search model 
(Protein Data Bank accession no. 2E3I). Data processing and refinement 
statistics  are  summarized  in  Table  S1.  The  atomic  coordinates  of  the 
CLIPCG1–SLAIN2c complex have been deposited in the Protein Data Bank 
(accession no. 3RDV).
Mass spectrometry
GST pull-down assays followed by mass spectrometry and streptavidin 
bead pull-down assays from HeLa cells followed by mass spectrometry 
were performed as previously described by Grigoriev et al. (2007). 1D 
SDS-PAGE gel lanes were cut into 2-mm slices using an automatic gel slicer 
and subjected to an in-gel reduction with dithiothreitol, alkylation with 
iodoacetamide, and digestion with trypsin (sequencing grade; Promega) 
essentially as previously described by Wilm et al. (1996). Nanoflow liquid 
chromatography with tandem mass spectrometry was performed on a cap-
illary liquid chromatography system (1100 series; Agilent Technologies) 
coupled to either an LTQ Orbitrap or an LTQ linear ion trap mass spectrom-
eter  (Thermo  Fisher  Scientific)  both  operating  in  positive  mode  and 
equipped with a nanospray source. Peptide mixtures were trapped on a 
reversed-phase column (ReproSil C18; Dr. Maisch GmbH; column dimen-
sions were 1.5 cm × 100 µm, packed in house) at a flow rate of 8 µl/min. 
Peptide  separation  was  performed  on  another  ReproSil  C18  reversed-
phase column (column dimensions were 15 cm × 50 µm, packed in house) 
using a linear gradient from 0 to 80% B (A, 0.1% formic acid; B, 80% 
[vol/vol] acetonitrile and 0.1% formic acid) in 70 min and at a constant 
flow rate of 200 nl/min using a splitter. The column eluent was directly 
sprayed into the electrospray ionization source of the mass spectrometer. 
Mass spectra were acquired in continuum mode; fragmentation of the pep-
tides was performed in the data-dependent mode. Peak lists were automati-
cally created from raw data files using the Mascot Distiller software (version 
2.1; Matrix Science). The Mascot search algorithm (version 2.2) was used 
for  searching  against  the  International  Protein  Index  database  (release 
number IPI_mouse_20100507.fasta or IPI_human_20100507.fasta). The 
peptide tolerance was typically set to 10 ppm for Orbitrap data and to 
2 D for ion trap data. The fragment ion tolerance was set to 0.8 D. A maxi-
mum number of two missed cleavages by trypsin were allowed, and carb-
amidomethylated cysteine and oxidized methionine were set as fixed and 
variable modifications, respectively. The Mascot score cut-off value for a JCB • VOLUME 193 • NUMBER 6 • 2011   1098
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For imaging of mitotic cells, we used a spinning-disc microscope 
(CSU-X1-A1; Yokogawa) equipped with a 405/491/561 triple band mir-
ror and GFP, mCherry, and GFP/mCherry emission filters (Chroma Tech-
nology Corp.) installed on an inverted research microscope (Eclipse Ti-E), 
which is almost identical to the one described previously in this section. The 
16-bit images were projected onto the CCD chip with a 2.0× intermediate 
lens at a magnification of 0.068 µm/pixel.
Images were prepared for publication using MetaMorph and Photo-
shop (Adobe). All images were modified by adjustments of levels and con-
trast; for images of live cells, averaging of several consecutive frames was 
performed in some cases. In addition to adjustments of levels and contrast, 
Unsharp Mask and Blur filters (Photoshop) were applied to tubulin images. 
Maximum intensity projection, kymograph analysis, and various quantifi-
cations were performed in MetaMorph. Statistical analysis was performed 
using a nonparametric Mann-Whitney U test in Statistica for Windows   
(Microsoft) and SigmaPlot (Systat Software, Inc.).
Measurement of parameters of MT dynamics
Two HeLa cell lines stably expressing GFP– or mCherry–-tubulin were used 
for the analysis at 72 h after transfection with SLAIN2 and ch-TOG siRNAs. 
The data were pooled because no significant differences were observed 
between the two lines for the measured parameters. Live-cell images were 
collected with 30, 10, and 2 frames per second. Initial analysis revealed no 
significant differences in the measured values. Therefore, all the data were 
averaged to obtain movies with a 0.5-s time interval for the final analysis. 
Parameters of MT growth were confirmed by independent measurements 
using HeLa cells stably expressing EB3-GFP. We applied kymograph analy-
sis in order to distinguish very short episodes of growth and shortening, 
which are relevant for describing the phenotypes of SLAIN2 and ch-TOG 
depletion. This led to much higher values for transition frequencies than 
those commonly determined using MT life history plots or particle-tracking 
algorithms for EB-GFP videos. For comparison, a similar analysis was per-
formed in Swiss 3T3 fibroblasts stably expressing EB3-GFP after siRNA 
transfection or in CHO cells after transient cotransfection of EB3-GFP and 
shRNA constructs. As we only focused on MT dynamics in internal cell re-
gions, we did not analyze the frequency and duration of pausing that is 
mostly associated with region-specific cortical MT stabilization. For mea-
surements of instantaneous growth and shortening rates, the velocity of MT 
end displacements that were longer than 0.5 μm were taken into account. 
Statistical analysis was performed using the Mann-Whitney U test.
Online supplemental material
Fig. S1 provides details of the mass spectrometry data on the identifica-
tion of SLAIN2 and ch-TOG as EB1-binding partners and illustrates dimer 
formation by the SLAIN2 N terminus and the specificity of anti-SLAIN1/2 
antibodies. Fig. S2 provides additional data on the SLAIN2–CLIP-170 
interaction. Fig. S3 provides details of the mass spectrometry analysis of 
SLAIN-binding  partners,  RT-PCR–based  data  on  expression  of  SLAIN1 
and 2 and characterization of SLAIN2-depleted cells. Fig. S4 provides 
additional data on SLAIN2-mediated ch-TOG binding to EB1 and to MT   
tips and the dominant-negative properties of the ch-TOG C terminus. 
Fig. S5 shows MT density after depletion or disruption of the SLAIN2–
ch-TOG  complex  and  MT  organization  and  dynamics  in  SLAIN2  and 
ch-TOG–depleted cells. Video 1 shows that GFP-SLAIN2 tracks growing 
MT ends in interphase HeLa cells. Video 2 shows that SxIP-like motifs of 
SLAIN2 contribute to its plus end–tracking behavior. Video 3 shows that 
GFP–ch-TOG colocalizes with mCherry-SLAIN2 at the plus ends of growing 
MTs. Video 4 shows MT plus end growth visualized with EB3-GFP in con-
trol, SLAIN2, and ch-TOG–depleted cells. Video 5 shows that GFP-SLAIN2 
does not track MT plus ends in metaphase cells. Video 6 shows that GFP-
SLAIN2 does not track MT plus ends in anaphase cells. Video 7 shows that 
GFP-SLAIN2 reassociates with MT plus ends in late telophase. Table S1 
provides  information  on  x-ray  data  collection  and  refinement  statistics. 
Table S2 provides the values and statistical analysis of the MT dynamics 
parameters. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201012179/DC1.
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